These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 541445)

  • 1. Equilibrium saturation chromatographic method for studying the binding of ligands to human serum albumin by high-performance liquid chromatography. Influence of fatty acids and sodium dodecyl sulphate on warfarin-human serum albumin binding.
    Sebille B; Thuaud N; Tillement JP
    J Chromatogr; 1979 Nov; 180(1):103-10. PubMed ID: 541445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of warfarin-human serum albumin protein binding parameters by an improved Hummel-Dreyer high-performance liquid chromatographic method using internal surface reversed-phase columns.
    Pinkerton TC; Koeplinger KA
    Anal Chem; 1990 Oct; 62(19):2114-22. PubMed ID: 2256548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of binding of low-molecular-weight ligand to biological macromolecules by high-performance liquid chromatography. Evaluation of binding parameters for two drugs bound to human serum albumin.
    Sebille B; Thuaud N; Tillement JP
    J Chromatogr; 1978 Dec; 167():159-70. PubMed ID: 757587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of binding of warfarin to serum albumins by high-performance liquid chromatography.
    Sun SF; Kuo SW; Nash RA
    J Chromatogr; 1984 Apr; 288(2):377-88. PubMed ID: 6736146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of long-chain fatty acids and albumin: determination of free fatty acid levels using the fluorescent probe ADIFAB.
    Richieri GV; Anel A; Kleinfeld AM
    Biochemistry; 1993 Jul; 32(29):7574-80. PubMed ID: 8338853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of specific albumin ligand markers used as modifiers on the separation of benzodiazepine enantiomers by chiral liquid chromatography on a human serum albumin column.
    Chosson E; Uzan S; Gimenez F; Wainer IW; Farinotti R
    Chirality; 1993; 5(2):71-7. PubMed ID: 8102067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influences of haemodialysis on the binding sites of human serum albumin: possibility of an efficacious administration plan using binding inhibition.
    Nishio T; Takamura N; Nishii R; Tokunaga J; Yoshimoto M; Kawai K
    Nephrol Dial Transplant; 2008 Jul; 23(7):2304-10. PubMed ID: 18390890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefazolin serum protein binding and its inhibition by bilirubin, fatty acids and other drugs.
    Decroix MO; Zini R; Chaumeil JC; Tillement JP
    Biochem Pharmacol; 1988 Jul; 37(14):2807-14. PubMed ID: 3395358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Warfarin binding to plasma albumin, measured in patients and related to fatty acid concentrations.
    Larsen FG; Larsen CG; Andersen S; Nørgaard A; Hansen HE; Brodersen R
    Eur J Clin Invest; 1986 Feb; 16(1):22-7. PubMed ID: 3084268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in the binding affinity of warfarin and phenprocoumon to human serum albumin in relation to surgery.
    Vorum H; Jørgensen HR; Brodersen R
    Eur J Clin Pharmacol; 1993; 44(2):157-62. PubMed ID: 8453960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retention data methods for the determination of drug-protein binding parameters by high-performance liquid chromatography.
    Sebille B; Thuaud N; Tillement JP
    J Chromatogr; 1981 Jan; 204():285-91. PubMed ID: 7217256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of fatty acids on the binding of warfarin and phenprocoumon to human serum albumin with relation to anticoagulant therapy.
    Vorum H; Honoré B
    J Pharm Pharmacol; 1996 Aug; 48(8):870-5. PubMed ID: 8887741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMR and computational studies reveal novel aspects in molecular recognition of unsaturated fatty acids with non-labelled serum albumin.
    Alexandri E; Primikyri A; Papamokos G; Venianakis T; Gkalpinos VK; Tzakos AG; Karydis-Messinis A; Moschovas D; Avgeropoulos A; Gerothanassis IP
    FEBS J; 2022 Sep; 289(18):5617-5636. PubMed ID: 35380736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of glycosylation on the drug binding of human serum albumin.
    Koizumi K; Ikeda C; Ito M; Suzuki J; Kinoshita T; Yasukawa K; Hanai T
    Biomed Chromatogr; 1998; 12(4):203-10. PubMed ID: 9667024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of the magnitude and enantioselectivity of ligand binding to rat and rabbit serum albumins using immobilized-protein high performance liquid chromatography stationary phases.
    Massolini G; Aubry AF; McGann A; Wainer IW
    Biochem Pharmacol; 1993 Oct; 46(7):1285-93. PubMed ID: 8216380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of indomethacin to human serum albumin. Its non displacement by various agents, influence of free fatty acids and the unexpected effect of indomethacin on warfarin binding.
    Zini R; D'Athis P; Barre J; Tillement JP
    Biochem Pharmacol; 1979 Sep; 28(17):2661-5. PubMed ID: 518678
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of free fatty acids on the binding of bovine and human serum albumin with steroid hormones.
    Watanabe S; Sato T
    Biochim Biophys Acta; 1996 Apr; 1289(3):385-96. PubMed ID: 8620023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple cobinding of two ligands to serum albumin: a stoichiometric description of binding equilibria.
    Larsen CG; Larsen FG; Jakobsen P; Brodersen R
    Arch Biochem Biophys; 1985 May; 239(1):74-86. PubMed ID: 4004264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel insights into the pleiotropic effects of human serum albumin in health and disease.
    Ha CE; Bhagavan NV
    Biochim Biophys Acta; 2013 Dec; 1830(12):5486-93. PubMed ID: 23602811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of alpha-1 acid glycoprotein, albumin, and nonesterified fatty acids in serum binding of apazone and warfarin.
    Urien S; Albengres E; Pinquier JL; Tillement JP
    Clin Pharmacol Ther; 1986 Jun; 39(6):683-9. PubMed ID: 3709033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.